AEZS - COSCIENS Biopharma Inc.
15 minute delayed price
5.721
0.321 5.611%
Share volume: 7,563
Last Updated: Thu 08 Aug 2024 09:34:35 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.40
0.32
5.94%
Summary score
13%
Profitability
0%
Dept financing
24%
Liquidity
68%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-17.69%
Return on assets
-11.37%
Return on sales
-2766.33%
Return on invested capital
-29.82%
Total debt ratio
93.52%
Debt ratio change over timeo
-2.56%
Current Ratio
3.25%
Quick Ratio
2.68%
Cash Position Ratio
2.84%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-67.11%
Return on assets
-9.05%
Return on sales
-5029.51%
Return on invested capital
-19.35%
Total debt ratio
102.17%
Debt ratio change over timeo
-0.26%
Current Ratio
2.77%
Quick Ratio
2.63%
Cash Position Ratio
2.23%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-370.57%
Return on assets
-8.44%
Return on sales
-2194.12%
Return on invested capital
-52.11%
Total debt ratio
94.73%
Debt ratio change over time
5.57%
Current Ratio
3.37%
Quick Ratio
3.22%
Cash Position Ratio
2.66%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-522.47%
Return on assets
-172.62%
Return on sales
15869.64%
Return on invested capital
-1066%
Total debt ratio
-255.66%
Debt ratio change over time
-2.56%
Current Ratio
-8.08%
Quick Ratio
-9.07%
Cash Position Ratio
-7.91%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AEZS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -17.69% | -3.05% | 11.55% | 6.27% |
| Return on assets | -11.37% | 3.6% | 3.57% | 5.27% |
| Return on sales | -2766.33% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -29.82% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 93.52% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -2.56% | 6.09% | 6.03% | 1.53% |
| Dept financing | 23% | 50% | 43% | 14% |
| Current Ratio | 2.77% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 2.63% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.23% | 1.48% | 0.76% | 1.49% |
| Liquididy | 68% | 27% | 55% | 59% |
| Short-term ratios | AEZS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -67.11% | -25.62% | 17.94% | 7.14% |
| Return on assets | -9.05% | 3.26% | 3.67% | 4.71% |
| Return on sales | -5029.51% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -19.35% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 102.17% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.26% | -23.44% | 9.66% | 0.6% |
| Dept financing | 24% | 25% | 45% | 8% |
| Current Ratio | 2.77% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 2.63% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.23% | 1.48% | 0.76% | 1.49% |
| Liquididy | 68% | 49% | 38% | 67% |